Sign In
Buy PFE
$25.36
-0.200 (-0.783%)
At Close: Jun 03, 2026
Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men
12:35pm, Monday, 01'st Dec 2025
Memo also reportedly mentions vaccines for flu and pneumonia.
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 8:00 a.m. EST on Tuesday, D
Moderna and Novavax Stocks Drop as FDA Proposes Stricter Vaccine Approvals
09:59am, Monday, 01'st Dec 2025
The FDA's top vaccine regulator outlines proposed changes to the vaccine evaluation process in an internal memo.
First Look: Airbus drops, Crypto slides, Cyber Monday
07:37am, Monday, 01'st Dec 2025
Stock News Airbus shares sink on fresh A320 quality snag: Airbus (EADSY) fell after reports of an industrial quality issue affecting fuselage panels on dozens o
2 Undervalued, High-Quality Companies to Buy Now and Hold Forever
09:05pm, Sunday, 30'th Nov 2025
Drug companies face fairly normal industry dynamics that can leave them unloved on Wall Street over short periods of time. Pfizer is facing a patent cliff and is making a big move to revamp its drug p
This 7% Yielder Could Be a Top AI Play
04:04pm, Sunday, 30'th Nov 2025
A looming patent cliff in which Pfizer will lose patent exclusivity to a handful of drugs has combined with cratering revenue from COVID-19 treatments to drive Pfizer shares down 50% since 2022. Pfize
3 Stocks to Buy and Hold: the Long-Term Play for Your Portfolio
06:30am, Sunday, 30'th Nov 2025
Intuitive Surgical shows why now is a good time to consider buying surgical-robot competitor Medtronic. Eli Lilly helps explain why down-and-out drugmaker Pfizer could be worth a close look for long-t
Pfizer: The Patent Cloud Is An Opportunity For Bargain Hunters
06:13am, Sunday, 30'th Nov 2025
Pfizer remains a compelling bargain, supported by a strong dividend yield and undervalued financial metrics, despite post-pandemic headwinds. PFE's acquisition of Metsera positions it for growth in th
Pfizer, Mastercard Among 24 Companies To Announce Annual Increases In December
11:59pm, Saturday, 29'th Nov 2025
This is my latest article, where I provide predictions of upcoming dividend increases from companies with long-term dividend growth histories. Most of the dividend increases announced in the last two
FDA's Prasad Cites Alleged Child COVID Shot Deaths in Push for Stricter Rules
02:52pm, Saturday, 29'th Nov 2025
FDA's new vaccine strategy tightens approval rules after internal findings linked COVID-19 shots to several child deaths.
8 'Safer' Dividend Buys In Barron's 23 Better November Bets Than T-Bills
11:00am, Friday, 28'th Nov 2025
Eight of the top fifteen Barron's Better Bets (BBB) 'Safer' dividend stocks, including Conagra, Altria, and Verizon, are currently attractively priced for income investors. Analyst forecasts project n
8 Dividend Stocks Every Investor Should Consider
05:30am, Friday, 28'th Nov 2025
Dividend investing isn't just about yield -- payout ratio and growth potential matter too. Several of these companies have increased dividends for decades without interruption.
Clarkston Capital Partners LLC Buys 15,000 Shares of Pfizer Inc. $PFE
03:45am, Friday, 28'th Nov 2025
Clarkston Capital Partners LLC boosted its stake in Pfizer Inc. (NYSE: PFE) by 22.5% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange C
Novo Nordisk or Pfizer: Which Healthcare Giant Is the Better Bet?
12:55pm, Thursday, 27'th Nov 2025
PFE's oncology gains and obesity re-entry contrast with NVO's GLP-1 pressures in this in-depth comparison of two healthcare giants.
Have $2,000 to Invest? Here Are 4 of My Favorite Dividend Stocks for the Next 5 Years
04:01am, Thursday, 27'th Nov 2025
Pfizer and Johnson & Johnson are healthcare leaders and faithful dividend payers. Home Depot is facing a difficult operating environment, but its core business remains strong.
